查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1521400

全球抗感染劑市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Anti-Infective Agents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格

全球抗感染藥物市場需求預計將從2023年的1,747億美元達到2032年近2,038.6億美元的市場規模，2024-2032年研究期間複合年成長率為1.73%。

抗感染劑是用於預防和治療各種病原體（包括病毒、細菌、真菌和寄生蟲）引起的感染的藥物。它們包括抗生素、抗病毒藥物、抗真菌藥物和抗寄生蟲藥物。這些藥劑透過抑制感染性生物體的生長或殺死感染性生物體發揮作用。抗感染藥物的選擇取決於感染類型、致病病原體和患者的健康狀況。正確使用這些藥物對於防止抗藥性的產生、確保有效治療感染和維護公眾健康至關重要。

市場動態

細菌、病毒、真菌和寄生蟲感染的發生率不斷上升，需要開發和使用有效的抗感染藥物。醫學研究的進步催生了新型抗生素、抗病毒藥物、抗真菌藥物和抗寄生蟲藥，解決了抗藥性菌株並改善了治療結果。人們越來越認知到早期和適當的感染治療的重要性，這也刺激了需求。此外，擴大發展中地區的醫療基礎設施和提高醫療服務的可近性也發揮著至關重要的作用。政府的支持措施和對傳染病研究的資助進一步刺激了市場。院內感染發生率的增加凸顯了對有效抗感染藥物的需求。製藥公司對研發、策略合作夥伴關係和藥物開發合作的投資加速了新型和先進抗感染藥物的推出，推動了市場成長。然而，抗藥性菌株的出現和治療的副作用可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球抗感染藥物市場的各個細分市場進行了包容性評估。抗感染劑產業的成長和趨勢為本研究提供了整體方法。

市場區隔

抗感染藥物市場報告的這一部分提供了有關國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按類型/藥物類別

  • 抗菌藥（頭孢菌素類、青黴素類、氟喹諾酮類、大環內酯類、碳青黴烯類等）
  • 抗病毒藥
  • 抗黴菌藥（唑類、棘白菌素類、多烯類、其他）

依給藥途徑

  • 專題
  • 口服
  • 四號
  • 其他

按配銷通路

  • 醫院藥房
  • 零售藥局
  • 專業藥房
  • 電子商務
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲抗感染藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。抗感染藥物市場的主要參與者包括輝瑞公司、雅培公司、吉利德科學公司、百時美施貴寶公司、默克公司、山德士國際有限公司、貝朗公司、Xellia Pharmaceuticals、Mankind Pharma、拜耳股份公司、阿斯特捷利康、勃林格殷格翰國際有限公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：抗感染劑 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型/藥品類別進行的市場吸引力分析
    • 按給藥途徑進行的市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球抗感染藥物市場分析：按類型/藥物類別

  • 按類型/藥物類別概述
  • 按類型/藥物類別進行歷史和預測資料分析
  • 抗菌藥（頭孢菌素類、青黴素類、氟喹諾酮類、大環內酯類、碳青黴烯類等）
  • 抗病毒藥
  • 抗黴菌藥（唑類、棘白菌素類、多烯類、其他）

第 6 章：全球抗感染藥物市場分析：依給藥途徑

  • 依給藥途徑概述
  • 按給藥途徑進行歷史和預測資料分析
  • 專題
  • 口服
  • 四號
  • 其他

第 7 章：全球抗感染藥物市場分析：按分銷管道

  • 配銷通路概述
  • 按配銷通路進行歷史和預測資料分析
  • 醫院藥房
  • 零售藥局
  • 專業藥房
  • 電子商務
  • 其他

第 8 章：全球抗感染藥物市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：抗感染藥物公司的競爭格局

  • 抗感染藥物市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Pfizer Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Abbott
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Gilead Sciences Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bristol-Myers Squibb Company
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck & Co. Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Sandoz International GmbH
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • B. Braun SE
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Xellia Pharmaceuticals
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Mankind Pharma
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bayer AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AstraZeneca
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Boehringer Ingelheim International GmbH
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112115203

The global demand for Anti-Infective Agents Market is presumed to reach the market size of nearly USD 203.86 Billion by 2032 from USD 174.7 Billion in 2023 with a CAGR of 1.73% under the study period 2024-2032.

Anti-infective agents are medications used to prevent and treat infections caused by various pathogens, including viruses, bacteria, fungi, and parasites. They include antibiotics, antivirals, antifungals, and antiparasitic drugs. These agents work by inhibiting the growth of or killing infectious organisms. The choice of anti-infective agent depends on the type of infection, the causative pathogen, and the patient's health condition. Proper use of these agents is essential to prevent the development of resistance, ensure effective treatment of infections, and safeguard public health.

MARKET DYNAMICS

The rising incidence of bacterial, viral, fungal, and parasitic infections necessitates the development and availability of effective anti-infective agents. Advances in medical research have led to the creation of novel antibiotics, antivirals, antifungals, and antiparasitics, addressing resistant strains and improving treatment outcomes. The growing awareness of the importance of early and appropriate infection treatment also boosts demand. Additionally, expanding healthcare infrastructure in developing regions and increasing accessibility to healthcare services play crucial roles. Supportive government initiatives and funding for infectious disease research further stimulate the market. The increasing occurrence of hospital-acquired infections underscores the need for effective anti-infective agents. Pharmaceutical companies' investment in R&D, strategic partnerships, and collaborations for drug development accelerate the introduction of new and advanced anti-infective agents, driving market growth. However, the emergence of resistant strains and side effects of treatments may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Anti-Infective Agents. The growth and trends of Anti-Infective Agents industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Anti-Infective Agents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type/Drug Class

  • Antibacterials (Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Others)
  • Antivirals
  • Antifungals (Azoles, Echinocandins, Polyenes, Others)

By Route of Administration

  • Topical
  • Oral
  • IV
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • E-Commerce
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Anti-Infective Agents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Anti-Infective Agents market include Pfizer Inc., Abbott, Gilead Sciences Inc., Bristol-Myers Squibb Company, Merck & Co. Inc., Sandoz International GmbH, B. Braun SE, Xellia Pharmaceuticals, Mankind Pharma, Bayer AG, AstraZeneca, Boehringer Ingelheim International GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ANTI-INFECTIVE AGENTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type/Drug Class
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANTI-INFECTIVE AGENTS MARKET ANALYSIS BY TYPE/DRUG CLASS

  • 5.1. Overview By Type/Drug Class
  • 5.2. Historical and Forecast Data Analysis By Type/Drug Class
  • 5.3. Antibacterials (Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Others) Historic and Forecast Sales By Regions
  • 5.4. Antivirals Historic and Forecast Sales By Regions
  • 5.5. Antifungals (Azoles, Echinocandins, Polyenes, Others) Historic and Forecast Sales By Regions

6. GLOBAL ANTI-INFECTIVE AGENTS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1. Overview By Route of Administration
  • 6.2. Historical and Forecast Data Analysis By Route of Administration
  • 6.3. Topical Historic and Forecast Sales By Regions
  • 6.4. Oral Historic and Forecast Sales By Regions
  • 6.5. IV Historic and Forecast Sales By Regions
  • 6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL ANTI-INFECTIVE AGENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Specialty Pharmacies Historic and Forecast Sales By Regions
  • 7.6. E-Commerce Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL ANTI-INFECTIVE AGENTS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ANTI-INFECTIVE AGENTS COMPANIES

  • 9.1. Anti-Infective Agents Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF ANTI-INFECTIVE AGENTS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Pfizer Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Abbott
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Gilead Sciences Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Bristol-Myers Squibb Company
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Merck & Co. Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Sandoz International GmbH
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. B. Braun SE
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Xellia Pharmaceuticals
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Mankind Pharma
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Bayer AG
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. AstraZeneca
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Boehringer Ingelheim International GmbH
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type/Drug Class (USD MN)
  • Antibacterials (Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Others) Market Sales By Geography (USD MN)
  • Antivirals Market Sales By Geography (USD MN)
  • Antifungals (Azoles, Echinocandins, Polyenes, Others) Market Sales By Geography (USD MN)
  • Analysis By Route of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • IV Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Specialty Pharmacies Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Anti-Infective Agents Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Anti-Infective Agents Report
  • Market Research Process
  • Market Research Methodology
  • Global Anti-Infective Agents Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type/Drug Class
  • Market Attractiveness Analysis By Route of Administration
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type/Drug Class (USD MN)
  • Antibacterials (Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Others) Market Sales By Geography (USD MN)
  • Antivirals Market Sales By Geography (USD MN)
  • Antifungals (Azoles, Echinocandins, Polyenes, Others) Market Sales By Geography (USD MN)
  • Global Market Analysis By Route of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • IV Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Specialty Pharmacies Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.